Entera Bio Ltd. (ENTX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Entera Bio Ltd.

    NASDAQ: ENTX · Real-Time Price · USD
    2.06
    -0.10 (-4.63%)
    At close: Sep 05, 2025, 3:59 PM
    2.05
    -0.49%
    After-hours: Sep 05, 2025, 07:51 PM EDT

    Entera Bio Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -9.54M -8.89M -13.07M -12.19M
    Depreciation & Amortization
    		 46K 56K 64K 53K
    Stock-Based Compensation
    		 2.56M 1.69M 2.25M 1.86M
    Other Working Capital
    		 189K -507K -1.62M 1.33M
    Other Non-Cash Items
    		 -5K n/a -78K 18K
    Deferred Income Tax
    		 14K 29K 174K -217K
    Change in Working Capital
    		 112K -195K -1.83M 1.41M
    Operating Cash Flow
    		 -6.82M -7.31M -12.5M -9.06M
    Capital Expenditures
    		 -3K -17K -47K -17K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a -55K n/a
    Investing Cash Flow
    		 -3K -17K -102K -17K
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a -580K 13K 3.58M
    Financial Cash Flow
    		 4.48M 6.04M 13K 25.38M
    Net Cash Flow
    		 -2.35M -1.29M -12.59M 16.3M
    Free Cash Flow
    		 -6.82M -7.33M -12.55M -9.08M

    Add to Watchlist